Hearing aids

Hearing aids has been studied in 108 papers since 2016: 21 trials and 51 observational studies in people, 34 reviews; 36 in the past year. The newest story, Oct 4, 2026: “Hearing aids did not cut dementia conversion in older adults”.

Intervention

108 papers study it97 findingsUpdated

MeSH

Research on it is growing 27% faster than aging research as a whole: 14 papers in the latest year counted

3 new papers in 30 daysSee all 107 papers on hearing aids

At a glance

Hearing aids improve cognition in human trials across independent labs, but other trials show no clear cognitive effect. Human cohorts link use with lower dementia risk, whereas a trial in people with mild cognitive impairment and moderate-to-severe hearing loss shows no clear dementia effect. Some papers declare company ties.

97 findings in 58 papers from 2017 to 2026, 12 of them since April 2026

Independent labs found the same change in people. 37 independent labs in 16 countries.

“The 3-year change in these proportions did not differ between the hearing intervention arm and the health education control participants.”
Effects of Hearing Intervention on Mobility Disability Over 3 Years: Findings From the ACHIEVE StudyGSA 2025 abstract2025doi:10.1093/geroni/igaf122.077

9 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 37 independent labs in 16 countries
  • 9 findings against
  • Funders: National Institute on Aging and others
  • 20 of 89 findings with company ties
  • Human trial20
  • Humans51
  • In silico1

17 studies gave hearing aids to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on dementiaRR, 0.59; 95% CI, 0.25-1.38

up: Improves cognitive functionRR, 5.94; 95% CI, 2.46-14.37

Randomized trial24-month703 peopleBothmean 74.53 years, range 60-96 yearsOlder adults with MCIJAMA neurology, Sep 28, 2026

down: Decreases GFAPdifference: −0.175; 95% CI: −0.322, −0.028

no change: Has no effect on NfLdifference: −0.159; 95% CI: −0.348, 0.029

Randomized trial3 years977 peopleBoth70–84 yearsCommunity-dwelling older adultsEClinicalMedicine, Sep 3, 2026

down: Decreases glial fibrillary acidic proteinmean -0.415 (95% CI -0.712, -0.118)

down: Decreases NfLmean -0.349 (95% CI -0.652, -0.046)

no change: Has no effect on neurodegeneration blood biomarkers

Randomized trial3 years164 people70–84 yearsOlder adults; in ARIC participants with untreated hearing lossGSA 2025 abstract, Dec 31, 2025

no change: Has no effect on functional limitations

no change: Has no effect on activities of daily living

no change: Has no effect on instrumental activities of daily living

Randomized trial3 years977 peopleolder adultsOlder adultsGSA 2025 abstract, Dec 31, 2025

up: Increases 18F-FDG uptake

Trial12 months28 peopleBothmean age=77.4 yearsOlder adults; early compared to late hearing aid interventionAAIC 2025 abstract, Dec 25, 2025

What did studies of hearing aids find?

46

Studies of hearing aids measured 46 outcomes; the most studied are cognitive function (10 studies), cognitive decline (7) and dementia (3).

Cognitive function

upin humans9no changein humans2RR 5.94

10 studies
  1. Hearing aids improve cognitive function in humans (RR, 5.94; 95% CI, 2.46-14.37).

    “The rate of cognitive improvement (CDR = 0) was 15.34% (95% CI, 11.84%-19.62%) in the intervention group and 2.36% (95% CI, 0.99%-5.22%) in the control group (RD, 12.00%; 95% CI, 8.79%-15.21%; RR, 5.94; 95% CI, 2.46-14.37).”

    Human trial24-month

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

  2. Hearing aids improve cognitive function in humans (mild cognitive impairment and moderate to severe hearing loss) (RR 5.94 (95% CI, 2.46-14.37)).

    “hearing intervention increased the rate of cognitive improvement (15.34%; 95% CI, 11.84%-19.62% vs 2.36%; 95% CI, 0.99%-5.22%; RD, 12.00%; 95% CI, 8.79%-15.21%; RR, 5.94; 95% CI, 2.46-14.37)”

    Human trialmild cognitive impairment and moderate to severe hearing loss24 monthsn = 703

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

  3. Hearing aids improve cognitive function in humans.

    “After six months of hearing aid use, we re-evaluated the MMSE and SRT scores and serum biomarkers levels in the ARHL group: we recorded significant improvements both in cognitive and word recognition tests and in biomarker values.”

    Human trialn = 30

    Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss

    Journal of clinical medicine

  4. Hearing aids showed no clear effect on cognitive function in older adults with hearing loss (Difference 0·002 [95% CI: −0·077, 0·081]).

    “In the analysis of the primary outcome of 3-year global cognitive change combining both the ARIC and de novo cohorts, global cognitive change (in SD units) was not significantly different between HI and SA control ( and; Difference 0·002 [95% CI: −0·077, 0·081], p=0·96).”

    Human trialin older adults with hearing loss3-yearn = 977

    Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial

    Lancet (London, England)

  5. Hearing aids showed no clear effect on cognitive function in humans (untreated hearing loss without substantial cognitive impairment) (difference 0·002 [-0·077 to 0·081]; p=0·96).

    “In the primary analysis combining the ARIC and de novo cohorts, 3-year cognitive change (in SD units) was not significantly different between the hearing intervention and health education control groups”

    Human trialuntreated hearing loss without substantial cognitive impairmentaudiological counselling and provision of hearing aids3 yearsn = 977

    Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial

    Lancet (London, England)

  6. Hearing aids improve cognitive function in humans (active +14.9 vs. sham +5.7, ES=0.62).

    “Hearing aid treatment as opposed to sham was associated with a significant improvement on RBANS Immediate Memory (active +14.9 vs. sham +5.7, ES=0.62, t=2.28, df=16, p=0.037).”

    Human trial12-weekn = 25

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  7. Hearing aids improve cognitive function in humans (comorbid MDD and moderate-profound hearing loss) (active +14.9 versus sham +5.7, t = 2.28, df = 16, p = 0.037).

    “and immediate memory (active +14.9 versus sham +5.7, t = 2.28, df = 16, p = 0.037)”

    Human trialcomorbid MDD and moderate-profound hearing loss12 weeks

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  8. Hearing aids improve cognitive function in humans (depressed older adults with age-related hearing loss) (np-ES = 0.25).

    “cognition (Repeatable Battery for the Assessment of Neuropsychological Status Immediate Memory [np-ES = 0.25])”

    Human trialdepressed older adults with age-related hearing lossfull amplification vs low-amplification sham12 weeksn = 13

    A pilot randomized controlled trial of hearing aids to improve mood and cognition in older adults

    International journal of geriatric psychiatry

  9. Hearing aids are linked with better cognitive function in humans (age-related hearing loss) (MoCA 24.49 ± 2.78 vs. 21.00 ± 3.63, MMSE 25.81 ± 2.45 vs. 23.33 ± 3.33).

    “The HA + group had significantly better MoCA (24.49 ± 2.78 vs. 21.00 ± 3.63; Z = -4.881, p < 0.001) and MMSE (25.81 ± 2.45 vs. 23.33 ± 3.33; Z = -4.118, p < 0.001) scores than the HA- group”

    Humansage-related hearing lossn = 104

    The protective role of hearing aids on delayed recall and spatial orientation in age-related hearing loss

    Frontiers in public health

  10. Hearing aids are linked with better cognitive function in humans (adjusted for covariates) (p = 0.003).

    “Hearing aid use was associated with higher PACC scores ( p = 0.003), suggesting a protective effect on cognitive function.”

    Humansadjusted for covariatesn = 420

    Hearing Impairment, Hearing Aid Use, and Cognitive Outcomes in Older Adults: A Cross‐Sectional Study

    AAIC 2025 abstract

All 14

Cognitive decline

downin humans7−48% protective effectHR 0.16

7 studies
  1. Hearing aids decrease cognitive decline in participants in the top quartile of predicted risk of cognitive decline (61.6% reduction (95% CI: 33.7%–94.1%)).

    “More precisely, covariate‐adjusted estimates indicated that the three‐way interaction between predicted risk, time, and treatment assignment was equivalent to a 61.6% (95% CI: 33.7%–94.1%) reduction in cognitive decline.”

    Human trialin participants in the top quartile of predicted risk of cognitive declinemedian follow-up time was 3.1 years (3.0, 3.2)

    Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Hearing aids decrease cognitive decline in humans (top quartile of predicted risk of cognitive decline) (61.6% slower (95% CI: 33.7%-94.1%)).

    “Among ACHIEVE participants in the top quartile of predicted risk, 3-year cognitive decline in the hearing intervention was 61.6% (95% confidence interval [CI]: 33.7%-94.1%) slower than the control.”

    Human trialtop quartile of predicted risk of cognitive decline3-yearn = 977

    Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  3. Hearing aids decrease cognitive decline in the ARIC cohort (-48%, Difference 0·191 [95% CI: 0·022, 0·360]).

    “In the ARIC cohort, HI was associated with a 48% reduction in 3-year cognitive change compared to SA control (Difference 0·191 [95% CI: 0·022, 0·360], p=0·027).”

    Human trialin the ARIC cohort3-yearn = 238

    Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial

    Lancet (London, England)

  4. Hearing aids are linked with lower cognitive decline in older adults with hearing loss.

    “participants with hearing aids showed a slower cognitive decline speed”

    Humansin older adults with hearing loss

    Hearing aids utilization, effect factors, and its benefit in the association between hearing and cognition decline: A longitudinal follow-up in Shanghai, China

    Experimental gerontology

  5. Hearing aids are linked with lower cognitive decline in humans (moderate hearing impairment) (HR 0.16 (0.04-0.64)).

    “A 2-year follow-up of participants with moderate hearing impairment yielded hazard ratios for MMSE score decrease of 0.30 (0.11-0.82) after 1 year and 0.16 (0.04-0.64) after 2 years in HA users.”

    Humansmoderate hearing impairment2 years

    Evaluation of the Association Between Hearing Aids and Reduced Cognitive Decline in Older Adults with Hearing Impairment

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

  6. Hearing aids are linked with lower cognitive decline in humans (β=-0.02 after vs β=-0.1 before, p<.001).

    “Decline in episodic memory scores was slower after (β=-0.02, p<.001) than before using hearing aids (β=-0.1, p<.001).”

    Humansn = 2,040

    Longitudinal Relationship Between Hearing Aid Use and Cognitive Function in Older Americans

    Journal of the American Geriatrics Society

  7. Hearing aids decrease cognitive decline in humans (48% protective effect).

    “One article found the provision of hearing aids would have a 48% protective effect on cognitive changes compared to the control over three years.”

    Reviewthree years

    HEARING LOSS AND COGNITIVE DECLINE: POLICY RECOMMENDATIONS

    GSA 2024 abstract

  8. Hearing aids decrease cognitive decline in participants most at risk for cognitive decline.

    “The participants most at risk for cognitive decline, with lower education, lower income, more likely to identify as Black, and have more cardiovascular risk factors, were the participants who benefited most from the hearing intervention”

    Reviewin participants most at risk for cognitive decline3 years

    Hearing loss and cognitive decline: Prioritizing equity in a world in which hearing health matters

    Alzheimer's & dementia (New York, N. Y.)

Dementia

no changein humans3RR 0.59

3 studies
  1. Hearing aids showed no clear effect on dementia in humans (RR, 0.59; 95% CI, 0.25-1.38).

    “As the primary outcome, the 24-month incidence of conversion from MCI to dementia-level impairment did not differ significantly between the intervention group (3.09%; 95% CI, 1.62%-5.74%) and the control group (4.74%; 95% CI, 2.60%-8.29%; RD, −2.07%, 95% CI, −4.74% to 0.61%; RR, 0.59; 95% CI, 0.25-1.38; P =.23”

    Human trial24-month

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

  2. Hearing aids showed no clear effect on dementia in humans (mild cognitive impairment and moderate to severe hearing loss) (RR 0.59 (95% CI, 0.25-1.38)).

    “No significant difference was observed in the primary outcome, in which the conversion rate from MCI to dementia-level impairment was 3.09% (95% CI, 1.62%-5.74%) in the intervention group vs 4.74%”

    Human trialmild cognitive impairment and moderate to severe hearing loss24 monthsn = 703

    Hearing aids did not cut dementia conversion in older adults

    JAMA neurology

  3. Hearing aids were not clearly linked with dementia in humans (poor hearing improvement) (HR = 0.98, 95% CI 0.90-1.07).

    “whereas those reporting poor hearing improvement show no reduced risk (HR = 0.98, 95% CI 0.90-1.07).”

    Humanspoor hearing improvement6.5-year average follow-up

    Hearing aid effectiveness and probable dementia risk across 33 countries: A pooled analysis of seven cohorts

    Cell reports. Medicine

  4. Hearing aids showed no clear effect on dementia in humans (reporting poor improvement in hearing) (HR 0.98).

    “no apparent benefit among those reporting poor improvement in hearing (HR 0.98)”

    Reviewreporting poor improvement in hearing

    From Hearing Aid Uptake to Hearing Aid Effectiveness: Rethinking Dementia Risk Reduction in Adults With Hearing Loss

    Sensory Neuroscience

More on Dementia

NfL

downin humans2no changein humans1

3 studies
  1. Hearing aids showed no clear effect on NfL in humans (difference: −0.159; 95% CI: −0.348, 0.029).

    “A comparable effect was observed for NfL (intervention: 0.171; 95% CI: 0.022, 0.319, control: 0.330; 95% CI: 0.185, 0.475, difference: −0.159; 95% CI: −0.348, 0.029; p-difference: 0.098), although the difference was not statistically significant.”

    Human trial3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

  2. Hearing aids showed no clear effect on NfL in humans (untreated hearing loss without substantial cognitive impairment) (difference: -0.159; 95 %CI: -0.348, 0.029).

    “NfL (intervention: 0.171; 95% CI: 0.022, 0.319, control: 0.330; 95 %CI: 0.185, 0.475, difference: -0.159; 95 %CI: -0.348, 0.029; p-difference: 0.098)”

    Human trialuntreated hearing loss without substantial cognitive impairmentplasma3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

  3. Hearing aids decrease NfL in ARIC participants with untreated hearing loss (mean -0.349 (95% CI -0.652, -0.046)).

    “Among ARIC participants, intervention resulted in lower 3-year GFAP(mean:-0.415;95%CI:-0.712,-0.118) and NfL(mean:-0.349;95%CI:-0.652,-0.046).”

    Human trialin ARIC participants with untreated hearing loss3 yearsn = 164

    Effects on Blood Neurodegeneration Biomarkers of a Randomized Hearing Rehabilitation Intervention

    GSA 2025 abstract

  4. Hearing aids decrease NfL in humans.

    “After six months of hearing aid use, we re-evaluated the MMSE and SRT scores and serum biomarkers levels in the ARHL group: we recorded significant improvements both in cognitive and word recognition tests and in biomarker values.”

    Human trialn = 30

    Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss

    Journal of clinical medicine

More on NfL

Depression

downin humans1no changein humans1

2 studies
  1. Hearing aids showed no clear effect on depression in humans (active −5.50 vs. sham - 7.32, ES=0.38).

    “No significant differences were found between hearing aid and sham groups on depressive symptoms (HRSD: active −5.50 vs. sham - 7.32, ES=0.38, t=0.75, df=19, p=0.464).”

    Human trial12-weekn = 25

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  2. Hearing aids showed no clear effect on depression in humans (comorbid MDD and moderate-profound hearing loss) (active -5.50 versus sham -7.32, t = 0.75, df = 19, p = 0.46).

    “No significant effect on depression was found (HRSD: active -5.50 versus sham -7.32, t = 0.75, df = 19, p = 0.46).”

    Human trialcomorbid MDD and moderate-profound hearing loss12 weeks

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  3. Hearing aids decrease depression in humans within a limited timeframe after diagnosis.

    “early adoption of hearing aids within a limited timeframe after diagnosis is linked to better cognitive performance, lower depressive symptom scores”

    Reviewwithin a limited timeframe after diagnosis

    Mood and Cognitive Disorders Following Hearing Loss: Impact of Hearing Aid Timing

    Audiology research

More on Depression

Cognitive impairment

no changein humans2OR 0.94

2 studies
  1. Hearing aids showed no clear effect on cognitive impairment in older adults with hearing loss (HR 0·90 [95% CI: 0·61, 1·33]).

    “HI was not associated with a reduced hazard of cognitive impairment in analyses of the total cohort (Hazard ratio [HR] 0·90 [95% CI: 0·61, 1·33], p=0·59) or in analyses stratified by the ARIC (HR 0·94 [95% CI: 0·54, 1·64], p=0·83) or de novo cohort (HR 0·89 [95% CI: 0·48, 1·67], p=0·72).”

    Human trialin older adults with hearing loss3-yearn = 977

    Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial

    Lancet (London, England)

  2. Hearing aids were not clearly linked with cognitive impairment in humans (compared with disabling HL without hearing aids) (OR 0.94, 95% CI 0.83-1.07).

    “The odds of cognitive impairment did not differ significantly between all participants with HA use and participants with disabling HL without HAs (OR, 0.94; 95% CI, 0.83-1.07)”

    Humanscompared with disabling HL without hearing aidsn = 62,072

    Hearing Loss, Hearing Aids, and Cognition

    JAMA network open

More on Cognitive impairment

GFAP

downin humans1

1 study
  1. Hearing aids decrease GFAP in humans (difference: −0.175; 95% CI: −0.322, −0.028).

    “Covariate-adjusted intention-to-treat analyses of three-year change in the primary analytic sample revealed that the hearing intervention was associated with a slower rise in GFAP”

    Human trial3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

  2. Hearing aids decrease GFAP in humans (untreated hearing loss without substantial cognitive impairment) (difference: -0.175; 95% CI: -0.322, -0.028).

    “hearing intervention was associated with a slower rise in GFAP (intervention: -0.026; 95% CI: -0.144, 0.093, control: 0.149; 95% CI: 0.039, 0.260; difference: -0.175; 95% CI: -0.322, -0.028; p-difference: 0.019)”

    Human trialuntreated hearing loss without substantial cognitive impairmentplasma3 yearsn = 164

    Effects of hearing intervention on blood-based biomarkers of neuroinflammation and neurodegeneration: a secondary analysis of the ACHIEVE randomised controlled trial

    EClinicalMedicine

More on GFAP

Falls

downin humans1

1 study
  1. Hearing aids decrease falls in humans (mean difference −0·54 (95% CI −0·77 to −0·31), 27% reduction).

    “corresponding to a 27% reduction in the mean number of falls over 3 years in the intervention group compared with the control group”

    Human trial3 yearsn = 977

    Effects of hearing intervention on falls in older adults: findings from a secondary analysis of the ACHIEVE randomised controlled trial

    The Lancet. Public health

  2. Hearing aids decrease falls in humans (untreated hearing loss and without substantial cognitive impairment) (27% reduction; mean difference: -0.54 [95% CI -0.77 to -0.31]).

    “the intervention group had a 27% reduction in the mean number of falls over 3 years compared with the control group”

    Human trialuntreated hearing loss and without substantial cognitive impairment3 yearsn = 977

    Effects of hearing intervention on falls in older adults: findings from a secondary analysis of the ACHIEVE randomised controlled trial

    The Lancet. Public health

Hearing Handicap Inventory-Elderly Screening version score

upin humans1

1 study
  1. Hearing aids improve hearing Handicap Inventory-Elderly Screening version score in humans (fully adjusted model).

    “Hearing intervention had a positive effect on perceived communicative function in both models at all time points.”

    Human trialfully adjusted model3 yearsn = 923

    Effect of hearing intervention on communicative function: A secondary analysis of the ACHIEVE randomized controlled trial

    Journal of the American Geriatrics Society

  2. Hearing aids improve hearing Handicap Inventory-Elderly Screening version score in humans (untreated mild-to-moderate hearing loss) (-9.5 points (95% CI: -11.0, -8.0) at Year 3).

    “Hearing intervention improved self-reported communicative function compared to a control intervention within 6 months and with effects sustained through 3 years.”

    Human trialuntreated mild-to-moderate hearing loss3 years

    Effect of hearing intervention on communicative function: A secondary analysis of the ACHIEVE randomized controlled trial

    Journal of the American Geriatrics Society

Hearing Handicap Inventory for the Elderly

downin humans1

1 study
  1. Hearing aids decrease Hearing Handicap Inventory for the Elderly in humans (active −12.47 vs. sham −4.19, ES=1.05).

    “As shown in, after adjusting for age, education and baseline scores, a significant improvement in HHIE was noted for the hearing aid compared to the sham group (active −12.47 vs. sham −4.19, ES=1.05, t=−2.64, df=18, p=0.016).”

    Human trial12-weekn = 25

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

  2. Hearing aids decrease Hearing Handicap Inventory for the Elderly in humans (comorbid MDD and moderate-profound hearing loss) (active -12.47 versus sham -4.19, t = -2.64, df = 18, p = 0.016).

    “hearing aids were effective at improving hearing functioning (Hearing Handicap for the Elderly: active -12.47 versus sham -4.19, t = -2.64, df = 18, p = 0.016)”

    Human trialcomorbid MDD and moderate-profound hearing loss12 weeksn = 19

    Hearing Rehabilitative Treatment for Older Adults With Comorbid Hearing Loss and Depression: Effects on Depressive Symptoms and Executive Function

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

More on Hearing Handicap Inventory for the Elderly

Story recall

upin humans1

1 study
  1. Hearing aids improve story recall in multi-talker babble.

    “Benefits increased with poorer hearing and, independently, with greater audibility gains from hearing aids.”

    Human trialin multi-talker babblen = 39

    Examining hearing-aid benefit during story listening in older adults using large language models

    medRxivPreprint

Sentence intelligibility

upin humans1

1 study
  1. Hearing aids improve sentence intelligibility in multi-talker babble.

    “On average, hearing aids improved sentence intelligibility and story recall.”

    Human trialin multi-talker babblen = 39

    Examining hearing-aid benefit during story listening in older adults using large language models

    medRxivPreprint

Listening and communication goal achievement

upin humans1

1 study
  1. Hearing aids improve listening and communication goal achievement in humans (adult-onset mild-to-moderate hearing loss).

    “Participant COSI goals, which included categories such as conversation in noise and in quiet or attending church and/or meetings, improved and were not dependent on technology used.”

    Human trialadult-onset mild-to-moderate hearing loss~10 weeksn = 459

    Patient-Centered Hearing Intervention Leads to Positive Outcomes: The Association of Hearing Technology With Daily Hearing Aid Usage and Listening Goals in the Aging and Cognitive Health Evaluation in Elders Study

    American journal of audiology

Instrumental activities of daily living

no changein humans1

1 study
  1. Hearing aids showed no clear effect on instrumental activities of daily living in humans.

    “The 3-year change in these proportions did not differ between the hearing intervention arm and the health education control participants.”

    Human trial3 years

    Effects of Hearing Intervention on Mobility Disability Over 3 Years: Findings From the ACHIEVE Study

    GSA 2025 abstract

Activities of daily living

no changein humans1

1 study
  1. Hearing aids showed no clear effect on activities of daily living in humans.

    “The 3-year change in these proportions did not differ between the hearing intervention arm and the health education control participants.”

    Human trial3 years

    Effects of Hearing Intervention on Mobility Disability Over 3 Years: Findings From the ACHIEVE Study

    GSA 2025 abstract

All 46

What is hearing aids linked with?

14

Studies link hearing aids with 14 measures, most often dementia (3 studies), cognitive function (2) and Parkinson's disease (2).

Dementia

downin humans3HR 0.91

3 studies
  1. Hearing aids are linked with a lower risk of dementia in humans (HR = 0.91, 95% CI 0.88-0.94).

    “hearing aid use is associated with reduced dementia risk (hazard ratio [HR] = 0.91, 95% confidence interval [CI] 0.88-0.94).”

    Humans6.5-year average follow-upn = 61,089

    Hearing aid effectiveness and probable dementia risk across 33 countries: A pooled analysis of seven cohorts

    Cell reports. Medicine

  2. Hearing aids are linked with a lower risk of dementia in individuals with hearing loss (RD -0.05, 95% CI -0.08, -0.01).

    “after 8 years of follow-up, risk of dementia was significantly lower among individuals who initiated hearing aids (risk difference (RD): -0.05, 95% confidence interval (CI): -0.08, -0.01).”

    Humansin individuals with hearing loss8 yearsn = 2,314

    Initiation of Hearing Aids Use and Incident Dementia Among Mid-to-late Life Adults: The Health and Retirement Study 2010-2018

    Journal of geriatric psychiatry and neurology

  3. Hearing aids lower the risk of dementia in adults with hearing loss (HR 0.91).

    “Hearing aid use was associated with a modestly lower risk of probable dementia overall (Hazard Ratios, HR, 0.91)”

    Reviewin adults with hearing lossn = 61,089

    From Hearing Aid Uptake to Hearing Aid Effectiveness: Rethinking Dementia Risk Reduction in Adults With Hearing Loss

    Sensory Neuroscience

More on Dementia

Cognitive function

upin humans2

2 studies
  1. Hearing aids are associated with cognitive function in humans (Individuals with hearing loss).

    “For SLUMS, the NH and HL-HA groups had significantly higher scores than the HL-no HA group”

    HumansIndividuals with hearing loss

    Impact of hearing loss and hearing aid use on cognitive performance among middle-aged adults

    The Egyptian Journal of Otolaryngology

  2. Hearing aids are associated with cognitive function in humans.

    “hearing rehabilitation, particularly hearing aid use, may be associated with more favorable cognitive outcomes.”

    Review

    Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation

    Neuro-degenerative diseases

Parkinson's disease

downin humans2

2 studies
  1. Hearing aids are linked with a lower risk of Parkinson's disease in humans (-9.2 cases per 10,000 person-years (95% CI: -10.7, -7.7)).

    “Dispensation of a hearing aid within two years of the audiogram attenuated the risk of incident PD”

    Humans2 years

    ASSOCIATION OF HEARING LOSS AND INCIDENT PARKINSON’S DISEASE: A COHORT STUDY IN US VETERANS

    GSA 2024 abstract

  2. Hearing aids are linked with a lower risk of Parkinson's disease in humans (-21.6 cases (95% CI, 19.5-23.6) at 10 years).

    “With prompt hearing aid dispensation, incident cases of PD decreased by 21.6 cases (95% CI, 19.5-23.6) at 10 years.”

    Humans10 years

    Hearing Loss, Incident Parkinson Disease, and Treatment With Hearing Aids

    JAMA neurology

More on Parkinson's disease

Mortality

downin humans1HR 0.91

1 study
  1. Hearing aids are associated with mortality in humans (current hearing-aid use) (HR 0.91 (95% CI 0.83–0.99)).

    “Current use of hearing aids was associated with reduced all-cause mortality risk [0·91 (95% CI 0·83-0·99)]”

    Reviewcurrent hearing-aid use

    Hearing loss linked to higher risk of death in adults

    The lancet. Healthy longevity

Cognitive impairment

downin humans1OR 0.76

1 study
  1. Hearing aids are linked with a lower risk of cognitive impairment in humans (unadjusted model) (OR = 0.76, p=.044).

    “HA use (OR = 0.76, p=.044) were both significantly associated with CI in the unadjusted model”

    Humansunadjusted model

    The Association Between Subjective Hearing Difficulty and Cognitive Impairment: A Stratified Analysis

    GSA 2025 abstract

More on Cognitive impairment

ADNC score

downin humans1RR 0.94

1 study
  1. Hearing aids are associated with ADNC score in humans among participants with documented hearing loss (RR 0.94 per unit increment, 95% CI 0.89–0.99).

    “Among 479 participants with documented hearing loss, hearing aid use was associated with lower ADNC level (RR per one unit increment in ADNC score: 0.94; 95% CI: 0.89, 0.99).”

    Humansamong participants with documented hearing lossn = 479

    Associations of hearing loss and hearing aid use with brain pathologies at autopsy in a community‐based cohort

    AAIC 2025 abstract

More on ADNC score

Depression

downin humans1

1 study
  1. Hearing aids are linked with a lower risk of depression in those with moderate to severe HL (aHR 0.65, 95% CI 0.49-0.87).

    “Hearing aid use (≥6 h self-reported use per day on average) in those with moderate to severe HL was associated with significantly reduced risk of incident depression (aHR: 0.65; 95% CI, 0.49-0.87, P < .01)”

    Humansin those with moderate to severe HL≥6 h per day on average

    The association between hearing impairment and incident depression in older adults: a longitudinal analysis

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Depression

Verbal memory scores

downin humans1

1 study
  1. Hearing aids are associated with verbal memory scores in humans.

    “Using a hearing aid was associated with lower verbal memory scores.”

    Humansn = 8,049

    HOW HEARING DIFFICULTIES AND SOCIAL ACTIVITIES SHAPE TRAJECTORIES OF COGNITIVE FUNCTION AMONG OLDER MEXICANS

    GSA 2024 abstract

Dementia diagnosis

upin humans1RR 1.43

1 study
  1. Hearing aids are associated with dementia diagnosis in humans (People with incident hearing loss; hearing aid users compared with nonusers) (RR 1.43, 95% CI 1.08–1.88).

    “HA users exhibited a higher risk of dementia diagnosis than nonusers (risk ratio: 1.43; 95% CI, 1.08-1.88).”

    HumansPeople with incident hearing loss; hearing aid users compared with nonusers

    A hypothetical intervention on the use of hearing aids for the risk of dementia in people with hearing loss in UK Biobank

    American journal of epidemiology

More on Dementia diagnosis

Osteogenesis imperfecta

upin humans1

1 study
  1. Osteogenesis imperfecta is associated with hearing aids in humans (SHR 4.16 [95% CI 3.21-5.40]).

    “Hearing aid use was more frequent in the OI cohort (SHR 4.16 [95% CI 3.21-5.40]) than in the Ref.Pop.”

    Humans

    The PATCH study: Prevalence of Hearing Loss During Ageing and Treatment Choices in Osteogenesis Imperfecta: A Danish Nationwide Register-Based Cohort Study

    Calcified tissue international

More on Osteogenesis imperfecta

All 14

Funding

15 grants since 2017

US Department of Veterans AffairsNational Institute on Aging$2MNational Institute on Deafness and Other Communication Disorders$1.9M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human trials report improved cognition but no dementia effect in people with mild cognitive impairment and moderate-to-severe hearing loss, and lower plasma GFAP but unchanged NfL in hearing loss without substantial cognitive impairment. Four findings span two independent labs; two findings come from papers declaring an interest involving the maker.

  2. Summary written from the findings.

Latest

Dec 2025: 8Jan 2026: 1Feb 2026: 2Mar 2026: 2Apr 2026: 3May 2026: 2Jun 2026: 5Jul 2026: 2Aug 2026: 1Sep 2026: 3Oct 2026: 5Nov 2026: 034 papers in 12 months
Research Square

Uncorrected hearing loss linked to memory decline at lower care access

A 10-year observational analysis of 2,397 older adults found no clear memory-decline link at high healthcare access among those with uncorrected hearing loss.A 10-year observational analysis of 2,397 older adults found no clear memory-decline link at high healthcare access among those with uncorrected hearing loss.

Preprint: cohort · 2,397 peopleHearing loss
The Lancet Healthy Longevity

Hearing loss linked to higher risk of death in adults

Compared with the reference group, relative rates of death were 1.19 for mild, 1.55 for moderate and 1.56 for moderately severe or worse hearing loss.Compared with the reference group, relative rates of death were 1.19 for mild, 1.55 for moderate and 1.56 for moderately severe or worse hearing loss.

Meta-analysis · 13,851 peopleHearing loss
JAMA Neurology

Hearing aids did not cut dementia conversion in older adults

Over 24 months, dementia conversion was 3.09% with hearing aids compared with 4.74% with hearing care education, a non-significant difference.Over 24 months, dementia conversion was 3.09% with hearing aids compared with 4.74% with hearing care education, a non-significant difference.

Randomized trial in 703 peopleHearing aids
The Journal of Prevention of Alzheimer's Disease

Probable dementia varied by race and ethnicity in older adults

Among adults aged 85 and older, model-adjusted probabilities of probable dementia were 60.2% for Hispanic adults and 35.1% for non-Hispanic White adults.Among adults aged 85 and older, model-adjusted probabilities of probable dementia were 60.2% for Hispanic adults and 35.1% for non-Hispanic White adults.

Cross-sectional · 7,574 peopleDementia

See all 107 papers on hearing aids